McKesson Corporation
MCK
株式のランク
#187
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
株価
$1,023.06
時価総額
$119.28B
変化（1日）
1.13%
変化（1年）
29.86%
国
US
取引 McKesson Corporation (MCK)
カテゴリー
Healthcare
McKesson Corporation（MCK）のP/E比率
October 2026 時点のP/E比率 TTM 26.02
McKesson Corporation の最新の財務報告および株価によると、現在の P/E (TTM) は 26.02 です。2024 年末時点での P/E は 23.80 でした。
McKesson Corporation の P/E 比率の履歴（2000 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 26.02 | 0.00% |
| 2025 | 26.02 | 9.31% |
| 2024 | 23.80 | 68.68% |
| 2023 | 14.11 | -66.28% |
| 2022 | 41.85 | -706.47% |
| 2021 | -6.90 | -125.37% |
| 2020 | 27.20 | -96.04% |
| 2019 | 686.13 | 56.89% |
| 2018 | 437.33 | 6,817.88% |
| 2017 | 6.32 | -60.53% |
| 2016 | 16.02 | -54.95% |
| 2015 | 35.55 | 11.06% |
| 2014 | 32.01 | 68.89% |
| 2013 | 18.96 | 23.18% |
| 2012 | 15.39 | -14.73% |
| 2011 | 18.05 | 28.94% |
| 2010 | 14.00 | 19.55% |
| 2009 | 11.71 | -23.94% |
| 2008 | 15.39 | -15.02% |
| 2007 | 18.12 | -16.19% |
| 2006 | 21.61 | -130.58% |
| 2005 | -70.69 | -623.74% |
| 2004 | 13.50 | 3.94% |
| 2003 | 12.99 | -49.58% |
| 2002 | 25.75 | -116.43% |
| 2001 | -156.79 | -2,020.83% |
| 2000 | 8.16 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| - | - |
US
|
|
| 34.08 | 30.96% |
US
|
|
| - | - |
US
|
|
| 45.62 | 75.31% |
AU
|
|
| 24.73 | -4.97% |
US
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。